Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)

NCT05027477 is registered in ClinicalTrials.gov with Profound Medical Inc. as lead sponsor.

NCT NCT05027477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05027477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)
Lead sponsor
Profound Medical Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 1, 2021
Completion date
August 31, 2036
Enrollment
201 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, prostate cancer